- Allo-SCT using BU, CY and melphalan for children with AML in second CR2013 | Second Faculty of Medicine
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study2020 | Second Faculty of Medicine
- Displacement of ethene from the decamethyltitanocene-ethene complex with internal alkynes, substituent-dependent alkyne-to- allene rearrangement, and the electronic transition relevant to the back-bonding interaction2015 | Faculty of Science, Central Library of Charles University
- Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia2022 | Publication without faculty affiliation
- CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics2022 | Second Faculty of Medicine
- Electroanalysis of some catecholamines at a single-wall nanotubes modified carbon paste electrode2010 | Faculty of Science
- Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes2018 | Second Faculty of Medicine
- Photoinduced Generation of Catalytic Complexes from Substituted-Titanocene-Bis(trimethylsisyl)ethyne Complex: Contribution to the Mechanism of the Catalytic Head-to-Tail Dimerization of Terminal Alkylnes1999 | Faculty of Science, Central Library of Charles University
- Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study2024 | Second Faculty of Medicine
- Decamethyltitanocene hydride intermediates in the hydrogenation of the corresponding titanocene-(eta(2)-ethene) or (eta(2)-alkyne) complexes and the effects of bulkier auxiliary ligands2017 | Faculty of Science, Central Library of Charles University
- WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience2021 | First Faculty of Medicine